Literature DB >> 26921499

ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.

Chaoju Gong1, Hong Liu2, Rui Song1, Tingting Zhong1, Meng Lou1, Tingyang Wang1, Hongyan Qi1, Jing Shen1, Lijun Zhu1, Jimin Shao3.   

Abstract

BACKGROUND: N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), an alkylating agent and an environmental carcinogen, causes DNA lesions and even carcinomas. DNA damage responses induced by MNNG activate various DNA repair genes and related signaling pathways. The present study aimed to investigate the regulatory mechanisms of human RR small subunit M2 (hRRM2) in response to MNNG.
RESULTS: In this study, we demonstrated that the RRM2 gene was transactivated by MNNG exposure more strongly than the other small subunit, p53R2. The upregulated RRM2 translocated to the nucleus for DNA repair. Further study showed that E2F3 transactivated RRM2 expression by directly binding to its promoter after MNNG exposure. The transactivation was enhanced by the upregulation of NFY, which bound to the RRM2 promoter adjacent to the E2F3 binding site and interacted with E2F3. In response to MNNG treatment, E2F3 accumulated mainly through its phosphorylation at S124 and was dependent on ATR-CHK1 signaling. In comparison, p53R2 played a relatively weaker role in the MNNG-induced DNA damage response, and its transcription was regulated by the ATR-CHK2-E2F1/p53 pathway.
CONCLUSIONS: We suggest that MNNG-stimulated ATR/CHK1 signaling stabilizes E2F3 by S124 phosphorylation, and then E2F3 together with NFY co-transactivate RRM2 expression for DNA repair. GENERAL SIGNIFICANCE: We propose a new mechanism for RRM2 regulation to maintain genome stability in response to environmental chemical carcinogens.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA repair; E2F3; Human ribonucleotide reductase small subunit M2 (RRM2); MNNG; Transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26921499     DOI: 10.1016/j.bbagrm.2016.02.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus.

Authors:  Satoko Iwahori; Robert F Kalejta
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  The TGFβ1-FOXM1-HMGA1-TGFβ1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression.

Authors:  Rongwei Zhang; Fuzheng Tao; Shenghui Ruan; Miaoxian Hu; Yanyan Hu; Zejun Fang; Lingming Mei; Chaoju Gong
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

3.  A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).

Authors:  Ying Z Mazzu; Joshua Armenia; Goutam Chakraborty; Yuki Yoshikawa; Si'Ana A Coggins; Subhiksha Nandakumar; Travis A Gerke; Mark M Pomerantz; Xintao Qiu; Huiyong Zhao; Mohammad Atiq; Nabeela Khan; Kazumasa Komura; Gwo-Shu Mary Lee; Samson W Fine; Connor Bell; Edward O'Connor; Henry W Long; Matthew L Freedman; Baek Kim; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2019-04-17       Impact factor: 12.531

4.  RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux.

Authors:  Haiping Jiang; Dongzhi Zhang; Karpov Denis Aleksandrovich; Junyi Ye; Lixiang Wang; Xiaofeng Chen; Ming Gao; Xinzhuang Wang; Tao Yan; He Yang; Enzhou Lu; Wenwu Liu; Cheng Zhang; Jianing Wu; Penglei Yao; Zhenying Sun; Xuan Rong; Sokhatskii Andrei Timofeevich; Safin Shamil Mahmutovich; Zhixing Zheng; Xin Chen; Shiguang Zhao
Journal:  Front Oncol       Date:  2022-05-11       Impact factor: 5.738

5.  Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest.

Authors:  Ruixue Yuan; Harmjan R Vos; Robert M van Es; Jing Chen; Boudewijn Mt Burgering; Bart Westendorp; Alain de Bruin
Journal:  EMBO J       Date:  2018-01-23       Impact factor: 11.598

6.  CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer.

Authors:  Zejun Fang; Aifen Lin; Jiaoe Chen; Xiaomin Zhang; Hong Liu; Hongzhang Li; Yanyan Hu; Xia Zhang; Jiangang Zhang; Lanlan Qiu; Lingming Mei; Jimin Shao; Xiang Chen
Journal:  Oncotarget       Date:  2016-11-22

7.  Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells.

Authors:  Pei-Ming Yang; Li-Shan Lin; Tsang-Pai Liu
Journal:  Biomolecules       Date:  2020-01-09

Review 8.  The broken cycle: E2F dysfunction in cancer.

Authors:  Lindsey N Kent; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2019-06       Impact factor: 60.716

9.  A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.

Authors:  Qian Liu; Lijuan Guo; Hongyan Qi; Meng Lou; Rui Wang; Boning Hai; Kailun Xu; Lijun Zhu; Yongfeng Ding; Chen Li; Lingdan Xie; Jing Shen; Xueping Xiang; Jimin Shao
Journal:  Cell Death Dis       Date:  2021-07-07       Impact factor: 8.469

10.  Longitudinal Analysis of Gene Expression Changes During Cervical Carcinogenesis Reveals Potential Therapeutic Targets.

Authors:  Lijun Yu; Meiyan Wei; Fengyan Li
Journal:  Evol Bioinform Online       Date:  2020-05-18       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.